Who makes 2800 ppm F as MFP?

2800 ppm F as MFP is developed by Procter and Gamble.

What development phase is 2800 ppm F as MFP in?

2800 ppm F as MFP is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

2800 ppm F as MFP

Procter and Gamble · FDA-approved active Small molecule Quality 0/100

2800 ppm F as MFP, marketed by Procter and Gamble, holds a significant position in the dental care market. The key composition patent, set to expire in 2028, provides a strong competitive advantage. The primary risk is the potential increase in competition following the patent expiry.

At a glance

Generic name	2800 ppm F as MFP
Sponsor	Procter and Gamble
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Salivary Fluoride Clearance (PHASE1)
Evaluation of the Fluoride Dose Response Using In Situ Caries Model (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

2800 ppm F as MFP CI brief — competitive landscape report
2800 ppm F as MFP updates RSS · CI watch RSS
Procter and Gamble portfolio CI